Pharmacy Practice
Affordable Medicines
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
mRNA Technology
May 23, 2022
Moderna Files for EUA for Pediatric mRNA Vaccine
May 23, 2022
Atopic Dermatitis Immunosuppressive Drugs and Efficacy With COVID-19 Vaccine
May 23, 2022
Evidence Reveals COVID-19 Vaccinations Protect Cancer Patients
March 17, 2022
Waning Effectiveness After Third COVID-19 Vaccine Dose
March 17, 2022
Adverse Effects With COVID-19 Vaccines Are Mild, Short-Lived
March 17, 2022
First Participant Dosed in HIV Trimer mRNA Vaccine
February 8, 2022
Study Explores Homologous and Heterologous COVID-19 Booster Vaccinations
February 8, 2022
Study: Effectiveness of COVID-19 Vaccines Over 9 Months in NC
February 8, 2022
First Participant Dosed in Phase 1 Study of mRNA EBV Vaccine
January 24, 2022
Moderna Announces Positive Phase I Data for mRNA Flu Vaccine
January 24, 2022
FDA Issues EUA for Pfizer and BioNTech COVID-19 Booster in Individuals Aged 12 Years and Older
January 24, 2022
Moderna Announces Booster Data, Strategy to Address Omicron Variant
December 10, 2021
Moderna Announces Measures to Address Omicron SARS-CoV-2 Variant
Load More
X
June 2022
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image